Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 131   

Articles published

GSK 1,656.61 -8.89 (-0.53%)
price chart
Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc
... stock to go with requires checking out the companies' product lineups, pipelines, and financial health. Digging into those details is exactly what's required in a head-to-head matchup between Pfizer Inc. (NYSE:PFE) and GlaxoSmithKline plc (NYSE:GSK).
Which is the better buy? GlaxoSmithKline plc vs Shire plc
Shire(LSE: SHP) and GlaxoSmithKline(LSE: GSK) are two of the UK's premier pharmaceutical companies but over the past five years, their fortunes couldn't have been more different.
A solid, defensive play for yield investors, but just what could sink GSK?
A decent defensive play and one for the yield investors is how one leading City broker described GlaxoSmithKline plc (LON:GSK) ahead of third-quarter figures next week.
GlaxoSmithKline PLC (GSK) Forecasted to Earn Q3 2016 Earnings of $0.78 Per Share
GlaxoSmithKline PLC logo GlaxoSmithKline PLC (NYSE:GSK) - Equities researchers at Leerink Swann upped their Q3 2016 earnings estimates for shares of GlaxoSmithKline PLC in a report issued on Thursday. Leerink Swann analyst S. Fernandez now ...
GlaxoSmithKline plc 15.4% Potential Upside Indicated by Investec
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Initiates/Starts' with the recommendation being set at 'BUY' today by analysts at Investec.
GlaxoSmithKline plc (GSK) PT Raised to GBX 1800  The Cerbat Gem
GlaxoSmithKline PLC (GSK) Coverage Initiated by Analysts at Investec  Community Financial News
Glaxo Sells Stake in South Africa's Aspen for $619 Million
GlaxoSmithKline Plc ended its seven-year run as an investor in Aspen Pharmacare Holdings Ltd., selling the final portion of its stake in the South African company for about $619 million.
GlaxoSmithKline to sell remaining stake in Aspen  MarketWatch
Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson
GlaxoSmithKline (NYSE:GSK) and Johnson & Johnson (NYSE:JNJ) are giants in their field, and they've both earned well-deserved reputations for taking advantage of opportunities in the pharmaceutical industry that have turned into sizable profits.
Glaxo to Pay $20 Million SEC Fine Over Bribery in China  Bloomberg
GlaxoSmithKline to pay $20 million to settle US foreign bribery case  Reuters
GlaxoSmithKline Plc (NYSE:GSK) Shrugs Skeptics Concerns To Launch Cold Flu ...
GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its unveiling.
Bryan, Garnier & Co Reiterates Buy Rating for GlaxoSmithKline plc (GSK)  The Cerbat Gem
Analysts Offer Predictions for GlaxoSmithKline PLC's FY2016 Earnings (GSK)  Community Financial News
GlaxoSmithKline plc 14.1% Potential Upside Indicated by Jefferies International
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Jefferies International.
GlaxoSmithKline plc (GSK) Given "Buy" Rating at Bryan, Garnier ...  BBNS
GlaxoSmithKline plc (GSK) Receives Consensus Rating of "Hold" from ...  Community Financial News
Defensive stocks showdown: GlaxoSmithKline plc vs Reckitt Benckiser Group plc
GlaxoSmithKline(LSE: GSK) and Reckitt Benckiser(LSE: RB) are two of the most defensive equities in the FTSE 100, but both have very different qualities.